The Gene Causing Multiple Endocrine Neoplasia Type 2 (MEN 2)

References

• Pachnis V, Mankoo B, Constantin' F. (1993). Expression of the c-ret proto-oncogene during mouse embryogenesis. Development 1993; 119:1005–17.
   Google Scholar
• Easton DF, Ponder MA, Cummings T, et al, and the CRC Medullary Thyroid Group. The clinical and screening age-at-onset distribution for the MEN 2 syndrome. Am J Hum Genet 1989; 44:208–15.
   PubMed Web of Science ®Google Scholar
• Verdy M, Weber AM, Roy CC, Morin CL, Cadotte M, Brochu P. Hirschsprung's disease in a family with MEN type 2. J Pediatr Gastroenterol Nutr 1982; 1: 603–7.
   PubMed Web of Science ®Google Scholar
• Farndon JR, DIBey WG, Baylin SB, Smaliridge RC, Harrison TS, Wells SA. Familial medullary thyroid carcinoma without associated endocrinopathies: a distinct clinical entity. Br J Surg 1986; 73: 278–81.
   PubMed Web of Science ®Google Scholar
• Dyck PJ, Carney A, Sizemore GW, Okazaki H, Brimijoin WS, Lambert E. Multiple endocrine neoplasia type 2B: phenotype recognition. Ann Neurol 1979; 6:302–14.
   PubMed Web of Science ®Google Scholar
• Ponder BAJ, Ponder MA, Coffey R, et al. Risk estimation and screening of families of patients with medullary thyroid carcinoma. Lancet 1988; i: 397–400.
   Google Scholar
• Gardner E, Pap' L, Easton DF, et al. Genetic linkage studies map the multiple endocrine neoplasia type 2 loci to a small interval on chromosome 10q11.2. Hum Mel Genet 1994; 2:241–6.
   Google Scholar
• Mole SE, Mulligan LM, Healey CS, Ponder BAJ, Tunna-clIffe A. Localisation of the gene for multiple endocrine neoplasia type 2A to a 480 kb region in chromosome band 10q11.2. Hum Mol Genet 1993; 2: 247–52.
   PubMed Web of Science ®Google Scholar
• Ulirlch A, Schlessinger J. Signal transduction by receptors with tyrosine kinase activity. Cell 1990; 61: 203–12.
   PubMedGoogle Scholar
• Mulligan LM, Kwok JBJ, Healey, et al. Germ-line mutations of the ret proto-oncogene in multiple endocrine neoplasia type 2A. Nature 1993; 363:458–60.
   PubMed Web of Science ®Google Scholar
• Mulligan LM, Eng C, Healey CS, et al. Specific mutations of the ret proto-oncogene are related to disease phenotype in MEN 2A and FMTC. Nature Genet 1994; 6: 70–4.
   PubMed Web of Science ®Google Scholar
• Donis-Keller H, Don S, Chi D, et al. Mutations in the ret proto-oncogene are associated with MEN 2A and FMTC. Hum Mol Genet 1993; 2: 851–6.
   PubMed Web of Science ®Google Scholar
• Hofstra RMW, Landsvater RM, Ceccherinl I, et al. A mutation in the ret proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma. Nature 1994; 367:375–6.
   PubMed Web of Science ®Google Scholar
• Schuchardt A, D'Agatl V, Larsson-Blom berg L, Casten-tini F, Pachnis V. Defects in the kidney and enteric nervous system of mice lacking the tyrosine kinase receptor ret Nature 1994; 367:380–2.
   Google Scholar
• Edery P, Lyonnet S, Mulligan LM, et al. Mutations of the ret proto-oncogene in Hirschsprung's disease. Nature 1994; 367:378–80.
   PubMed Web of Science ®Google Scholar
• Romeo G, Ronchetto P, Luo Y, et al. Point mutations affecting the tyrosine kinase domain of the ret proto-oncogene in Hirschsprungs disease. Nature 1994; 367: 377–8.
   PubMed Web of Science ®Google Scholar
• Telenius-Berg M, Berg B, Hamberger B, et al. Impact of screening on prognosis in the multiple endocrine neoplasia type 2 syndromes: natural history and tretment results in 105 patients. Henry Ford Hosp Med j 1984; 32: 225–32.
   PubMedGoogle Scholar
• Gagel RF, Tashjian AH Jr, Cummings, et al. The clinical outcome of prospective screening for multiple endocrine neoplasia type 2A. N Engl J Med 1988; 318: 478–84.
   PubMedGoogle Scholar
• Eng C, Smith DP, Mulligan LM, et at. Point mutation within the tyrosine kinase domain of the ret proto-oncogene in multiple endocrine neoplasia type 2B and related sporadic tumours. Hum Mol Genet 1994; 3: 237–41.
   PubMed Web of Science ®Google Scholar
• McMahon R, Mulligan LM, Healey CS, et al. Direct non radioactive detection of mutations in multiple endocrine neoplasia type 2A families. Hum Mol Genet 1994 (in press).
   Google Scholar
• Telenius H, Mathew CGP, Nakamura Y, et al. Application of linked DNA markers to screening families with multiple endocrine neoplasia type 2A. Eur J Surg Oncol 1990; 16: 134–40.
   PubMedGoogle Scholar